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Signal transduction systems coordinate complex cellular information to regulate biological
events such as cell proliferation and differentiation. Although the accumulating evidence
on widespread association of signaling molecules has revealed essential contribution
of phosphorylation-dependent interaction networks to cellular regulation, their dynamic
behavior is mostly yet to be analyzed. Recent technological advances regarding mass
spectrometry-based quantitative proteomics have enabled us to describe the compre-
hensive status of phosphorylated molecules in a time-resolved manner. Computational
analysesbasedonthephosphoproteomedynamicsaccelerategenerationofnovelmethod-
ologies for mathematical analysis of cellular signaling. Phosphoproteomics-based numeri-
cal modeling can be used to evaluate regulatory network elements from a statistical point
of view. Integration with transcriptome dynamics also uncovers regulatory hubs at the tran-
scriptional level.These omics-based computational methodologies, which have ﬁrstly been
applied to representative signaling systems such as the epidermal growth factor receptor
pathway, have now opened up a gate for systems analysis of signaling networks involved
in immune response and cancer.
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INTRODUCTION
Signal transduction networks are known to regulate complex bio-
logical events in orchestration with subsequent transcriptional
regulation (Hunter, 2000; Schlessinger, 2000). Previous in-depth
analyses on cell signaling under a variety of experimental condi-
tions have revealed many of the key molecules and related events
thatresultineachbiologicaleffect.Regardingtheintensivelystud-
ied signaling systems such as the epidermal growth factor (EGF)
receptor pathway, the accumulated experimental evidence has
clearly demonstrated the complexity of the interaction network
involved in the signaling (Oda et al., 2005; Jones et al., 2006).
As phosphorylation-dependent protein interaction networks play
a major role in transmitting signals, a comprehensive and ﬁne
description of their status would contribute substantially toward
understanding the regulatory mechanisms at the system level.
Recent proteomics technology based on high-resolution mass
spectrometry (MS) has enabled us to quantitatively describe the
activation dynamics on phosphorylated signaling molecules in a
comprehensive and unbiased manner (Blagoev et al.,2004; Zhang
et al.,2005;Olsen et al.,2006;Oyama et al.,2009). Computational
systems analysis based on the phosphoproteome dynamics data
paves the way to theoretical approaches for deﬁning regulatory
principles that govern complicated signaling processes. Some sta-
tistical methodologies including mathematical modeling (Tasaki
et al.,2006,2010),Bayesian network (Bose et al.,2006;Guha et al.,
2008), or partial least square regression (Wolf-Yadlin et al., 2006;
Kumar et al., 2007) have already been applied to EGF signaling.
An integrated approach based on both phosphoproteomic and
transcriptomic data has also revealed a global view of cellular
regulation at the transcriptional level (Oyama et al., 2011). In
thisarticle,weintroducetherecentprogressof proteomics-driven
computational analyses applied to the signaling behavior of rep-
resentative biological pathways and the potential impact on the
system-level analyses of heterogeneous signaling networks related
to immune response and cancer.
EMERGENCE OF HIGH-THROUGHPUT
PHOSPHOPROTEOMICS TECHNOLOGY FOR LARGE-SCALE
IDENTIFICATION AND QUANTIFICATION OF CELLULAR
PHOSPHORYLATED MOLECULES
Recent advancement in liquid chromatography–tandem mass
spectrometry (LC–MS/MS) measurement technology has greatly
improved the throughput and sensitivity of protein measure-
ments. We can now identify thousands of proteins in a single
study (Brunner et al., 2007; de Godoy et al., 2008). In order to
efﬁciently describe the status of phosphorylated molecules,a vari-
ety of biochemical methodologies have been developed for their
enrichment. Immobilized metal afﬁnity chromatography (IMAC;
Stensballe et al.,2001; Ficarro et al.,2002),strong cation exchange
(SCX) chromatography (Ballif et al.,2004; Beausoleil et al.,2004),
metal oxide chromatography (MOC; Pinkse et al., 2004; Larsen
et al., 2005) were intensively evaluated as core analytical method-
ologies in the previous reports. For targeting tyrosine phosphory-
lation,anti-phosphotyrosineantibodieswereappliedtoefﬁciently
purify the corresponding molecules (Rush et al., 2005). Through
these sophisticated enrichment methods, current shotgun pro-
teomics technology based on high-resolution LC–MS/MS has
enabled the detection of thousands of phosphorylated molecules
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FIGURE1|S c hematic procedure for comprehensive identiﬁcation
and quantiﬁcation of phosphorylated proteins by shotgun
proteomics technology.The phosphorylated molecules differentially
encoded with stable isotopes for each interval of stimulation are
enriched through afﬁnity puriﬁcation and analyzed by high-resolution
nanoLC–MS/MS system.
from representative cell lines such as human HeLa cells (Figure1;
Olsen et al., 2006, 2010).
Another important advance in MS-based systems analysis is
developmentofprotein/peptidelabelingstrategiesforquantitative
proteomics (Figure 1). Several methodologies for in vivo/in vitro
labeling have been established for relative quantiﬁcation of the
activationstatusof signalingmolecules.Therepresentative in vivo
protein labeling methodology termed stable isotope labeling by
amino acids in cell culture (SILAC) can be conducted by incor-
porating distinguishable stable isotopes into speciﬁc amino acid
residues such as lysine and arginine during cell culture (Ong et al.,
2002, 2003). Another approach to introduce differential labels
in vitro is chemical tagging of speciﬁc amino acid residues such
as cysteine. The isotope-coded afﬁnity tag (ICAT), which consists
of a cysteine-directed reactive group, a linker with stable isotope
signatures, and a biotin tag, is applied to purify labeled peptides
bybiotin–avidinafﬁnity(Gygietal.,1999;Hanetal.,2001).Asfor
amine-directed tagging, the isobaric tag for relative and absolute
quantitation (iTRAQ) enables comparative quantiﬁcation of four
or eight samples in a single analysis (Ross et al.,2004).
By combining these technologies, time-resolved activation
proﬁles of ligand-induced phosphoproteome were depicted in
a quantitative manner (Figure 2). The original approach to
describe phosphotyrosine-dependent signaling dynamics led
to the identiﬁcation of 81 effectors in human HeLa cells
upon EGF stimulation (Blagoev et al., 2004). The global
phosphoserine/threonine/tyrosine-related proteome analysis for
the EGF signaling system in the same cell line yielded a network-
wide view of the dynamic behavior of 6,600 phosphorylation sites
on 2,244 proteins (Olsen et al., 2006).
In a recent study, a highly time-resolved description of
EGF/EGFR signaling was measured in human epithelial A431
cells (Oyama et al., 2009). The quantitative activation data on
the EGF-regulated tyrosine-phosphoproteome were measured at
10 time points after EGF stimulation (0, 0.5, 1, 2, 5, 10, 15, 20,
25, and 30min), generating a detailed view of their multi-phase
network dynamics. In this study, temporal perturbation of the
signaling dynamics was also conducted with a kinase inhibitor to
clearly distinguish between sensitive and robust pathways to this
treatment. This approach showed that phosphoproteomics-based
time-resolved description of the network dynamics functioned as
an analytical basis for evaluating temporal perturbation effects
in relation to speciﬁc signaling interactions, leading us to obtain
a system-level view of the regulatory relationships in signaling
dynamics.
COMPUTATIONAL MODELING OF SIGNAL TRANSDUCTION
NETWORKS BASED ON QUANTITATIVE PHOSPHOPROTEOME
DATA
Although phosphoproteomics-based temporal description of
signaling networks provides system-level information on
dynamic regulation of signal transduction via phosphoryla-
tion/dephosphorylation, the most important challenge for elu-
cidating the mechanistic aspects of signal transduction is the
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FIGURE 2 |Time-resolved description of signaling networks by quantitative proteomics.Time-course activation proﬁles of phosphorylated molecules are
generated through integration of a series of fold activation data that were measured at different time points.
establishment of statistical methodologies for performing com-
putational modeling with increasing species, states, and reactions
over the signaling network. In a recent study, some computa-
tional frameworks have been developed for analyzing ﬂux-based
signaling information on quantitative phosphoproteomics data
(Figure 3). In the initial approach, self-organizing maps were
applied to identify EGF signaling modules based on time-resolved
description of 78 tyrosine phosphorylation sites on 58 proteins in
human mammary epithelial 184A1 cells (Zhang et al., 2005). The
cells with varying human ErbB2 (HER2) expression levels were
further analyzed to characterize HER2-mediated signaling effects
on cell behavior (Wolf-Yadlin et al., 2006). Partial least squares
regression (PLSR) was applied to estimate the phosphotyrosine
clusters exhibiting self-similar temporal activation proﬁles, lead-
ing to identiﬁcation of the signals that were strongly correlated
withcellmigrationandproliferationandcouldfunctionasa“net-
work gage” of cell fate control (Wolf-Yadlin et al., 2006; Kumar
et al.,2007).
Bayesian network modeling based on multiple sets of quan-
titative phosphoproteome data could generate probabilistic net-
works that represented core aspects of the models with a directed
graph of inﬂuence on protein phosphorylation. In combination
with the literature-based protein–protein interaction data on the
EGFR/ErbB signaling, this statistical approach not only recapitu-
lated known portions of the signaling pathways but also inferred
novel relationships between the related molecules (Bose et al.,
2006;Guhaetal.,2008).Inarecentstudy,acomputationalframe-
work based on data assimilation was also developed for analyz-
ing mutated EGFR signaling through phosphoproteomics-driven
numerical modeling (Tasaki et al., 2010). The hybrid functional
petri net with extension (HFPNe) is a computational modeling
architecture which can deal with discrete biological events as well
ascontinuousonesandenablesustoanalyzetemporaldataonbio-
logical entities such as phosphorylated signaling molecules within
the data assimilation framework. The HFPNe-based computa-
tional modeling of aberrant EGFR signaling led to reduction of
the factors responsible for mutational effect to several alterations
inthereactionparametersandprovidedamechanisticdescription
of thedisordersof theircellsignalingnetworksatthesystemlevel.
Phosphoproteome dynamics data can be integrated with the
transcriptome dynamics to analyze the regulatory mechanisms
more systematically. In a very recent study, time-resolved phos-
phoproteome and transcriptome data on 17β-estradiol (E2) and
heregulin (HRG)-induced signal-transcription programs were
quantitatively analyzed to elucidate regulatory pathways in breast
cancer signaling (Oyama et al., 2011). Reconstruction of protein
interaction networks based on the phosphoproteome data shed
light on the activated signaling molecules over the network,while
statistical evaluation of transcription factor-binding site motif
signiﬁcance for the entire gene expression data led us to focus
on the core transcriptional regulators. Functional association of
these factors using pathway databases revealed ligand-dependent
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FIGURE 3 | Computational approaches for analyzing network properties of phosphorylation-dependent signaling behavior. Phosphoproteomics-based
network models, in combination with literature-based network/pathway information, can be sophisticated to interpret regulatory aspects of signaling dynamics.
signal-transcription regulatory programs in both of wild type and
drug-resistant breast cancer MCF-7 cells,leading us to extract the
pathways activated in drug-resistant cells.
FUTURE PROSPECTS
Recent advances in proteomics technology have presented us with
a system-wide view of phosphorylation-dependent signaling net-
work dynamics in a quantitative manner. Mathematical analysis
of phosphoproteomics-basednetworkswillleadtoabetterunder-
standing of the critical factors controlling network behavior and
provideacomputationalplatformtoexplorepotentialdrugtargets
for speciﬁc disease conditions and theoretically estimate the effect
of thecorrespondingdrugsonanetwork-widescalepriortoclini-
calapplication.Assignalingnetworkstructuresdependoncellular
context (Morandell et al., 2008), cell-speciﬁc signaling network
architectures need to be described independently using phospho-
proteomics to characterize the behavior of each signaling system.
Although this emerging technology has been applied to only a
limited fraction of signaling networks including the EGFR path-
way, further accumulation and integration of phosphoproteome
data on heterogeneous immune and cancer signaling networks
should accelerate elucidation of general and condition-speciﬁc
principles that govern signaling network behavior and pave the
way to understanding complex cellular responses from a systems
perspective.
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